SCHEMBL26568482

SCHEMBL26568482

Ic1ccc(-c2ccc(-c3ccc4ccc(-c5ccc(-c6ccc7sc8ccccc8c7c6)cc5)cc4c3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.44
MAPT P10636 4/20 0.38
ESR1 P03372 3/20 0.38
ESR2 Q92731 3/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PIM3 Q86V86 1/20 0.36
CYP1A2 P05177 1/20 0.35
KDM4E B2RXH2 1/20 0.34
F9 P00740 2/20 0.34
PTPN7 P35236 1/20 0.34
DUSP3 P51452 1/20 0.34
PTPN12 Q05209 1/20 0.34
PTPN22 Q9Y2R2 1/20 0.34
LIMK1 P53667 1/20 0.34
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26553579 1.00 GPR3 (0.44) GPR3MAPTESR1ESR2ALDH1A1
SCHEMBL26552674 0.95 GPR3 (0.45) GPR3MAPTESR1ESR2ALDH1A1
SCHEMBL26551111 0.95 GPR3 (0.45) GPR3MAPTESR1ESR2ALDH1A1
SCHEMBL17197600 0.92 GPR3 (0.52) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL21170629 0.92 GPR3 (0.52) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL26555358 0.87 HSD17B1 (0.36) GPR3RAB9APIM3LIMK1ROCK1
SCHEMBL15893265 0.87 GPR3 (0.50) GPR3MAPTESR1ESR2ALDH1A1
SCHEMBL18086205 0.85 GPR3 (0.52) GPR3MAPTESR1ESR2ALDH1A1
SCHEMBL15945895 0.85 GPR3 (0.52) GPR3MAPTESR1ESR2ALDH1A1
SCHEMBL26548956 0.84 GPR3 (0.44) GPR3MAPTESR1ESR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 GPR3 4702/4885MAPT 2621/4885ESR1 940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.